Brandon Capital Invests in Neuroscience Company NRG Therapeutics
Brandon Capital, Australasia’s leading life science venture capital firm, is pleased to announce its investment into neuroscience company NRG Therapeutics as part of its £16m (AUD$29m) series A financing. Brandon Capital participated alongside Omega Funds, which led the round, as well as NRG’s founding investor ...
Source: pharmiweb.com